AVITA Medical Q4 Earnings Summary & Key Takeaways
Benzinga Insights 8 months ago
Earnings
AVITA Medical (NASDAQ:RCEL) released its Q4 earnings on Thursday, February 12, 2026 at 04:01 PM.
Here's what's important from the earnings announcement.
Earnings
AVITA Medical beat estimated earnings by 19.15%, reporting an EPS of $-0.38 versus an estimate of $-0.47.
Revenue was down $790 thousand from the same period last year.
Analysis of Past Earnings
Last quarter the company missed on EPS by $0.02 which was followed by a 10.88% increase in the share price the next day.
Here's a look at AVITA Medical's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.44 | -0.32 | -0.51 | -0.74 |
| EPS Actual | -0.46 | -0.38 | -0.53 | -0.44 |
| Revenue Estimate | 27.70M | 34.27M | 32.79M | 31.59M |
| Revenue Actual | 16.90M | 18.42M | 18.51M | 18.41M |
To track all earnings releases for AVITA Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.